Marksans Pharma shares in focus after block deals worth ₹257 crore

Shares of Marksans Pharma Ltd. will be in focus on Wednesday, June 11, after a large trade took place in the pharmaceutical company.

As many as 1.02 crore shares changed hands in the block deal, according to data available on the exchanges.

Shares changed hands at an average price of ₹250 per share. The total transaction value is said to be ₹257 crore.

CNBC-TV18 had reported that global healthcare investment firm, OrbiMed Asia IV Mauritius FVCI Ltd intend to sell 2.27% stake in the company through block deals. The deal size stood at ₹256.8 crore.

Buyers and sellers in the transaction is not known officially.

As of the March-end quarter, OrbiMed Asia IV Mauritius FVCI Ltd had a 10.88% stake in the company.

Marksans Pharma posted a 15.6% year-on-year increase in consolidated net profit for the fourth quarter of FY25, rising to ₹90.5 crore from ₹78 crore. Revenue for the quarter grew 26.5% to ₹708.5 crore, compared to ₹560 crore in the same period last year.

Shares of Marksans Pharma Ltd. settled 1.32% lower on Tuesday at ₹250. The stock has tumbled nearly 20% so far in 2025.